Tissue stiffness promotes pro-fibrotic metabolic dysregulation in lung fibrosis

Ended Project Grant Awarded Last action

Award ID
F32HL154525
Recipient
Awarding agency
Obligated
$210,612

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Place of performance
Virginia, USA

Award details come from USAspending.gov.

About this award

Virginia Commonwealth University was awarded a $210,611.86 Project Grant from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute on January 31, 2021. The grant supports research under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate "Tissue Stiffness Promotes Pro-Fibrotic Metabolic Dysregulation in Lung Fibrosis." This two-year project aims to foster basic research on the relationship between tissue stiffness and metabolic dysregulation in the development of lung fibrosis. Specifically, the university will study how mechanical forces influence fibrotic metabolic pathways that drive the progression of scarring in the lungs. Insights from this research could help identify novel therapeutic targets for treating and preventing lung fibrosis.

Transactions

Action Obligated Date
Amendment -$4,442
Amendment $1,276
Amendment $1,276
Amendment $1,276
Amendment $72,958
Amendment $72,958
Original award $65,310

Quick answers

Who received award F32HL154525?

F32HL154525 was awarded to Virginia Commonwealth University by National Heart Lung and Blood Institute (National Institutes of Health) on January 31, 2021.

How much is award F32HL154525 worth?

$210,612 has been obligated on F32HL154525.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award